| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9409494 | Brain Research Bulletin | 2005 | 6 Pages |
Abstract
RNAi has moved from a purely experimental technique to the stage of potential clinical applications. The possible use of RNAi in the treatment of spinocerebellar ataxia or amyotrophic lateral sclerosis, with its advantages and pitfalls and possible extensions to other diseases are discussed.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Vladimir Pekarik,